Brainstorm Cell Therapeutics Inc. (BCLI) dropped -8.17% or -0.29 to $3.26. It is approximately 28861 shares traded, which is 61.22% compare to the average total volume 47145. The market cap of BCLI is $67.51 million. The year to date change is -10.91%. The 52 week price range is from $2.88 to $5.35. Price of BCLI have changed 16.39% during last week. It have changed 13.42% over last month, -8.51% over last 3 months, -14.87% over last 6 months and 17.94% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for BCLI is 3.22. It is -1.23% below current price. The 200-day Moving Averages for BCLI is 3.72. It is 14.11% above current price. The 52-week High is 5.35. It is 64.11% from the current price. The 52-week Low is 2.88. It is -11.66% from current price.
There are some statistics of BCLI. It is has market cap $67.51 million. The share outstanding is 20.71 million. The average volume is 47145. The percent of top 15 Institution holding is 15.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of BCLI is -109.26%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of BCLI is -66.04%.